Job Description
Compensation: 20–25% Uncapped Commission + Advisory Equity Structure: Commission-Only Partner (Independent Contractor)
The Opportunity: Sell "Alpha," Not Software We are floatz. We use AI to stress-test the science behind biotech deals. Our tech predicted the Rubius Therapeutics collapse ($200M+ loss) 2 years early. We are seeking a Strategic Sales Partner to bridge the gap between our engine and the Buy-Side. You aren't a rep; you are a channel owner. You leverage your existing trust with Portfolio Managers to sell "Drawdown Protection" (Scientific Risk Audits).
You provide the access; we provide the "Soft Dollar" (Section 28e) product that closes in <3 weeks. Who You Are (
The "Must Haves") You are a Hunter with an active rolodex. You fit one of these profiles: • The Expert Network Alumnus (GLG/AlphaSights): You are tired of selling $1,000 phone calls. You want to sell $25k strategic audits. • The Institutional Sales Rep: You know "Soft Dollars" and have PMs on speed dial. • The Cap Intro Connector: You want to monetize your network as a Principal, not an employee.
You speak the language: • You know why a Phase 2 readout is a binary event. • You understand "Netting Risk" and "Pass-Through Expenses."
The Role • Your Job: Open the door. Book a "Risk Review" with a PM holding a specific biotech ticker. • Our Job: Close the deal. Our PhD team proves the risk and handles the paperwork. The Deal • Commission: 20-25% of Revenue (Uncapped). Sell a $25k audit → Keep $6,250. • Equity: Advisory Equity kicker based on revenue milestones. ⛔ DO NOT APPLY IF... • You want a "Base
Salary."
This is for those who bet on themselves.
• You have never sold directly to a Hedge Fund. • You are used to 9-month SaaS sales cycles. We move fast. Apply tot his job Apply tot his job